Psychedelic trips often unfold without issues, but what if a trip needs to be stopped? Drugs such as benzodiazepines and antipsychotics are recommended as rescue medications and have been around for decades. Can ketanserin be used as a more targeted trip stopper?
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
Patent filings indicate that CaaMTech was the first company to propose an entourage effect in psychedelic compounds.
This company is approaching psychedelic mushroom research literally from the ground up.
This technology developed by MindMed and Liechti Lab may help ease some of the concerns surrounding psychedelic therapy.
The scope and validity of this patent will depend on how x-ray diffraction data is interpreted.